Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2006-1-6
pubmed:abstractText
To analyze prognostic and predictive effects of immunohistochemical factors within a randomized study of high-dose versus standard-dose chemotherapy in high-risk breast cancer with >10 involved lymph nodes.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1078-0432
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
159-68
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:16397038-Adult, pubmed-meshheading:16397038-Antineoplastic Agents, pubmed-meshheading:16397038-Breast Neoplasms, pubmed-meshheading:16397038-Female, pubmed-meshheading:16397038-Genes, Tumor Suppressor, pubmed-meshheading:16397038-Genes, p16, pubmed-meshheading:16397038-Humans, pubmed-meshheading:16397038-Immunohistochemistry, pubmed-meshheading:16397038-Ki-67 Antigen, pubmed-meshheading:16397038-Lymphatic Metastasis, pubmed-meshheading:16397038-Middle Aged, pubmed-meshheading:16397038-Predictive Value of Tests, pubmed-meshheading:16397038-Prognosis, pubmed-meshheading:16397038-Proto-Oncogene Proteins c-bcl-2, pubmed-meshheading:16397038-Receptor, erbB-2, pubmed-meshheading:16397038-Serpins, pubmed-meshheading:16397038-Survival Analysis, pubmed-meshheading:16397038-Survival Rate, pubmed-meshheading:16397038-Tumor Markers, Biological, pubmed-meshheading:16397038-Tumor Suppressor Protein p53
pubmed:year
2006
pubmed:articleTitle
Prognostic and predictive effects of immunohistochemical factors in high-risk primary breast cancer patients.
pubmed:affiliation
Department of Bone Marrow Transplantation, Transplant Center, Hamburg-Eppendorf, Hamburg, Germany. nkroeger@uke.uni-hamburg.de
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Multicenter Study